EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Female-specific alterations in insulin dynamics are associated with glucose tolerance in a Glut1DS mouse model

Tamio Furuse iD, Tomoko Kushida, Akiko Shinogi, Mao Ozaki, Ryoko Yanagisawa, Masaru Tamura

Disease Models & Mechanisms · 2026

DOI: 10.1242/dmm.052836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Tamio Furuse und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mouse Phenomics Division, RIKEN BioResource Research Center, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan. Hauptthemen laut MEDLINE: Insulin, Carbohydrate Metabolism, Inborn Errors, Glucose Transporter Type 1, Glucose. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RIKEN, GLUT1 Deficiency Foundation, RIKEN BRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucose transporter type 1 deficiency syndrome (Glut1DS) is a rare autosomal dominant genetic disorder caused by mutations in SLC2A1, which results in impaired glucose transport across the blood−brain barrier. Patients with Glut1DS present with various symptoms, including seizures, delayed development and movement disorders. The current first-line therapy − ketogenic diet − has shown variable efficacy, highlighting the need to explore alternative therapeutic strategies. This study aimed to investigate comprehensive phenotypic characteristics of the Glut1DS mouse model B6(D2)-Slc2a1<Rgsc200>/1Rbrc to establish foundational data for identifying novel therapeutic targets. The Slc2a1Rgsc200 mutant mouse was phenotypically characterized at the Japan Mouse Clinic of the RIKEN BioResource Research Center by using a phenotyping pipeline that included intraperitoneal glucose tolerance test (IPGTT) and clinical blood chemistry analyses. Heterozygous Glut1DS mutants exhibited no differences in basal plasma glucose or glycosylated hemoglobin A1c levels when compared to wild-type controls. However, female heterozygous mutants showed decreased glucose levels during IPGTT, accompanied by increased plasma insulin levels following glucose administration. These findings support recent evidence linking insulin signaling to seizure control in patients with Glut1DS, as demonstrated in human studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinCarbohydrate Metabolism, Inborn ErrorsGlucose Transporter Type 1GlucoseMonosaccharide Transport ProteinsAnimalsFemaleDisease Models, AnimalGlucose Tolerance TestPhenotypeBlood GlucoseMutationHeterozygoteMaleMice

Stichwörter der Autor:innen

Glucose metabolismGlut1DSInsulin secretionMouse modelSLC2A1

Substanzen

InsulinGlucose Transporter Type 1Blood GlucoseGlucoseMonosaccharide Transport ProteinsSlc2a1 protein, mouse

Autor:innen und Institutionen

  • Mouse Phenomics Division, RIKEN BioResource Research Center, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.

ORCID-Profile: Tamio Furuse

Förderung

  • RIKEN
  • GLUT1 Deficiency Foundation
  • RIKEN BRC

Zitieren

APA

Furuse, T., Kushida, T., Shinogi, A., Ozaki, M., Yanagisawa, R., & Tamura, M. (2026). Female-specific alterations in insulin dynamics are associated with glucose tolerance in a Glut1DS mouse model. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052836

Vancouver

Furuse T, Kushida T, Shinogi A, Ozaki M, Yanagisawa R, Tamura M. Female-specific alterations in insulin dynamics are associated with glucose tolerance in a Glut1DS mouse model. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052836

BibTeX
@article{Furuse2026,
  author = {Furuse, Tamio and Kushida, Tomoko and Shinogi, Akiko and Ozaki, Mao and Yanagisawa, Ryoko and Tamura, Masaru},
  title = {Female-specific alterations in insulin dynamics are associated with glucose tolerance in a Glut1DS mouse model},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  doi = {10.1242/dmm.052836}
}
Kostenlos starten →